Genetic Newborn Screening for Cystinosis and Primary Hyperoxaluria

NARecruitingINTERVENTIONAL
Enrollment

200,000

Participants

Timeline

Start Date

March 15, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
CystinosisPrimary Hyperoxaluria
Interventions
DIAGNOSTIC_TEST

Diagnostic test

Test for two mutations in the CTNS gene and one mutation in the PH1 gene and PH 3.

Trial Locations (1)

30430

RECRUITING

Screening Laboratory Hanover, Hanover

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Screening Laboratory Hannover

UNKNOWN

collaborator

Pediatry Kastanienhof Koeln

UNKNOWN

collaborator

Medical Genetics Mainz

UNKNOWN

collaborator

University Hospital Cologne

UNKNOWN

lead

Cystinose Stiftung

OTHER